At a glance

ClinicalIndex Comparison Record

N/ACompleted· 209 enrolled

Drug / intervention

HIV D+/R+other

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03500315

NCT03500315N/ACompleted

Compare CT.gov

HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

Johns Hopkins University·interventional·Posted Apr 18, 2018·Updated Jul 23, 2024

In Brief

A clinical study evaluating HIV D+/R+ for Hiv. Completed, enrolled 209 participants across 29 sites.

Detailed Summary

The primary objective of this study is to determine if an HIV-infected deceased kidney donor (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complications.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHiv

CountriesUnited States

CollaboratorsNational Institute of Allergy and Infectious Diseases (NIAID)

Timeline

N/ACompletedFinished

20192020202120222023202420252026

First PostedApr 2018

Enrollment StartApr 2018

Primary CompletionSep 2022

Study CompletionMay 2024

TodayJul 2026

First PostedApr 18, 2018

Enrollment StartApr 19, 2018

Primary CompletionSep 30, 2022

Study CompletionMay 1, 2024

TodayJul 2, 2026

Enrollment to primary: 4.4 yearsPosted 8.2 years ago

Interventions

HIV D+/R+other

Kidney from an HIV-infected deceased donor